• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Complementary and Integrative Medicine in Pancreatic Cancer
This article reviews research findings on the beneficial effect of use of CIM modalities in regard to pancreatic cancer, with emphasis on pancreatic ductal adenocarcinoma (PDAC).Recent FindingsGiven the often-poor prognosis of the disease, patients with PDAC often seek integrative therapies to help manage the disease itself, to provide support through cancer treatment and its symptoms, and to provide emotional stress relief. Data is accumulating in the past few years on the potential benefits of CIM to the management of pancreatic cancer symptoms and treatment side effects, in order to augment supportive care. This data re...
Source: Current Oncology Reports - February 3, 2023 Category: Cancer & Oncology Source Type: research

Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients
AbstractComplementary and alternative medicine (CAM) is used by many cancer patients by themselves. Therefore, we conducted a survey regarding the association between CAM, self-efficacy, and patient activation in adult cancer patients. A standardized questionnaire, consisted of the ASKU, the PAM 13-D, and a structured questionnaire on CAM usage from our own working group, was distributed to 880 potential participants. Six hundred and thirty-nine (639) patients (male 32.9%, female 63.2%; gynecological cancer 41%, gastrointestinal 19.2%, urogenital 15.6%) took part. 60% of all patients used CAM in the last 3  months (biolog...
Source: Medical Oncology - September 7, 2022 Category: Cancer & Oncology Source Type: research

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
ConclusionOur results reveal a high incidence of interactions between CAM and antineoplastic agents. The most frequent CAM were herbal products. Family and friends were the primary sources of information that led patients to start taking CAM, and more than half of the patients did not tell their doctor that they were taking CAM.
Source: Journal of Cancer Research and Clinical Oncology - July 6, 2022 Category: Cancer & Oncology Source Type: research

Determinants of use of oral complementary-alternative medicine among women with early breast cancer:  a focus on cancer-related fatigue
ConclusionOne-in-four patients reported use of OCAM. More severe CRF was consistently associated with its use. Moreover, older, better educated, wealthier, more anxious women, and those receiving chemotherapy seemed more prone to use OCAM. Characterizing profiles of BC patients more frequently resorting to OCAM may help deliver targeted information about its benefits and potential risks.
Source: Breast Cancer Research and Treatment - September 24, 2021 Category: Cancer & Oncology Source Type: research

Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients
Conclusion: There is a considerable demand for integrative medicine among breast and gynecological cancer patients. Our results underline the need for the implementation of evidence-based integrative treatments in cancer care in order to meet the standards of modern oncology.Breast Care
Source: Breast Care - October 24, 2018 Category: Cancer & Oncology Source Type: research